Foto del docente

Walter Cabri

Professore ordinario

Dipartimento di Chimica "Giacomo Ciamician"

Settore scientifico disciplinare: CHIM/06 CHIMICA ORGANICA

Pubblicazioni

Brevetto n. WO2021191832, Process for the Synthesis of Propofol.

Brevetto n. WO2019008520, A Process for Preparing Alectinib or a Pharmaceutically Acceptable Salt Thereof.

Brevetto n. WO2019043587, A Process for the Preparing Treosulfan.

Brevetto n. WO2019082143, An Improved Process for The Preparation of Ribociclib and its Salts.

Ferrazzano, L ; Corbisiero, D ; Martelli, G; Tolomelli, A ; Viola, A ; Ricci, A; Cabri, W, Green Solvent Mixtures for Solid-Phase Peptide Synthesis: A Dimethylformamide-Free Highly Efficient Synthesis of Pharmaceutical-Grade Peptides, «ACS SUSTAINABLE CHEMISTRY & ENGINEERING», 2019, 7, pp. 12867 - 12877 [articolo]Open Access

Brevetto n. US11566058, Improved process for the preparation of high purity glucagon.

Timo Nuijens; Ana Toplak; Marcel Schmidt; Antonio Ricci; Cabri W, Natural Occurring and Engineered Enzymes for Peptide Ligation and Cyclization, «FRONTIERS IN CHEMISTRY», 2019, 7, pp. 829 - 837 [articolo]

Viola, A ; Ferrazzano, L ; Martelli, G ; Cerisoli, L ; Ricci, A; Tolomelli, A; Cabri, W, Novel insights into the chemistry of an old medicine: A general degradative pathway for penicillins from a piperacillin/tazobactam stability study, «EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES», 2019, 136, Article number: UNSP 104957, pp. 1 - 9 [articolo]

Guryanov I.; Orlandin A.; Viola A.; Biondi B.; Badocco D.; Formaggio F.; Ricci A.; Cabri W., Overcoming Chemical Challenges in the Solid-Phase Synthesis of High-Purity GnRH Antagonist Degarelix. Part 1, «ORGANIC PROCESS RESEARCH & DEVELOPMENT», 2019, 23, pp. 2746 - 2753 [articolo]

Brevetto n. EP19207738, Process for the Manufacture of Derivatized Amino Acids.

Brevetto n. EP19161404, Process for the preparation of Degarelix.

Brevetto n. WO2019202057, A Method for Production of High Purity Icatibant".

Brevetto n. WO2018150386, An Improved Process for the Preparation of Boronic Acid Esters.

Brevetto n. WO2018158697, An Improved Process for the Preparation of Ixazomib citrate.

Brevetto n. IN201811024212, An Improved Process for The Preparation of Venetoclax.

Ultimi avvisi

Al momento non sono presenti avvisi.